PHARMA-THIM
ActiveSummary
PHARMA-THIM has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €357k and a net result of €60k. Equity is growing by ~35.4% per year across the filed fiscal years. Its solvency ranks better than 64% of 6537 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2024
Axes · tick = 2023
Profitability78▼-3
Solvency71▲+10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25k at 30 days acceptable
Liquidity ample (current ratio 1.52 against 1.21 in 2023; short-term debt: 26.1% and cash: 11.3% of total assets), but 54.3% of the assets are financed with debt.
Credit check for your own amount and term
Open the credit simulator : see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-09-2025, 61 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
61 d late
2023
58 d late
2022
29 d late
2021
61 d late
2020
109 d late
2019
143 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit simulator What should you check before you do business with this company?Supplier due diligence Accepting this client? The AML file with identity, beneficial owners and sanctions lists.AML client file How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed Roughly what is this company worth?Value indication
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€60k▼ 25.3%
2023 · €81k
Working capital
€107k▲ 113%
2023 · €50k
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€104k▲ 121%€56k▼ 46.3%€121k▲ 117%€137k▲ 12.8%€115k▼ 15.6%
Net result€54k▲ 789%€18k▼ 66.5%€63k▲ 251%€81k▲ 27.5%€60k▼ 25.3%
Equity€134k▲ 67.3%€152k▲ 13.5%€215k▲ 41.7%€296k▲ 37.5%€357k▲ 20.4%
Total assets€858k▼ 10.4%€786k▼ 8.4%€818k▲ 4.0%€816k▼ 0.2%€780k▼ 4.4%
Debt€724k▼ 17.5%€634k▼ 12.4%€602k▼ 5.1%€520k▼ 13.7%€423k▼ 18.6%
Working capital€47k▲ 129%€42k▼ 10.4%€15k▼ 63.6%€50k▲ 226%€107k▲ 113%
Staff (FTE)1.8▲ 125%2▲ 11.1%2=1.2▼ 40.0%1.2=
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 16% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €780k
Fixed assets
€470k ▼ 11.1%
Current assets
€310k ▲ 7.8%
Equity and liabilities €780k
Equity
€357k ▲ 20.4%
Debt
€423k ▼ 18.6%
Debt's share of the balance-sheet total falls from 63.7% to 54.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€176k▼
2023 · €199k
Cash flow
€121k▼
2023 · €143k
Current ratio
1.52▲
2023 · 1.21
Quick ratio
0.86▲
2023 · 0.65
Debt to equity
1.19▼
2023 · 1.75
ROE
16.9%▼
2023 · 27.3%
ROA
7.7%▼
2023 · 9.9%
Interest coverage
12.77▲
2023 · 12.45
Debt ≤ 1 year
€204k▼
2023 · €238k
Debt > 1 year
€220k▼
2023 · €280k
Income taxes
€41k▲
2023 · €40k
Staff costs
€62k▲
2023 · €59k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €45k | €52k | €59k | €62k | ▲ 5.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €90k | €90k | €87k | €63k | €61k | ▼ 2.3% |
| Other operating charges640/8 | - | €6k | €10k | €5k | €3k | ▼ 36.8% |
| Gross operating margin9900 | €222k | €197k | €270k | €263k | €242k | ▼ 8.1% |
| Operating profit (loss)9901 | €104k | €56k | €121k | €137k | €115k | ▼ 15.6% |
| Financial income75/76B | - | €180 | €44 | €67 | - | - |
| Recurring financial income75 | €168 | €180 | €44 | €67 | - | - |
| Financial charges65/66B | - | €22k | €19k | €16k | €14k | ▼ 14.0% |
| Recurring financial charges65 | €25k | €21k | €18k | €16k | €14k | ▼ 13.6% |
| Non-recurring financial charges66B | - | €451 | €287 | €81 | - | - |
| Profit (loss) for the period before taxes9903 | €79k | €34k | €103k | €121k | €102k | ▼ 15.8% |
| Income taxes67/77 | €25k | €16k | €39k | €40k | €41k | ▲ 3.4% |
| Profit (loss) for the period9904 | €54k | €18k | €63k | €81k | €60k | ▼ 25.3% |
| Profit (loss) for the period to be appropriated9905 | €54k | €18k | €63k | €81k | €60k | ▼ 25.3% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €858k | €786k | €818k | €816k | €780k | ▼ 4.4% |
| Fixed assets21/28 | €621k | €543k | €570k | €528k | €470k | ▼ 11.1% |
| Intangible fixed assets21 | €317k | €284k | €252k | €219k | €187k | ▼ 14.8% |
| Tangible fixed assets22/27 | €304k | €258k | €317k | €307k | €281k | ▼ 8.5% |
| Land and buildings22 | - | €222k | €312k | €287k | €267k | ▼ 7.1% |
| Plant, machinery and equipment23 | - | €26k | €5k | €7k | €4k | ▼ 43.1% |
| Furniture and vehicles24 | - | €912 | €129 | €13k | €11k | ▼ 21.2% |
| Leasing and similar rights25 | - | €10k | €0 | - | - | - |
| Financial fixed assets28 | - | - | €2k | €2k | €2k | = |
| Current assets29/58 | €237k | €244k | €247k | €288k | €310k | ▲ 7.8% |
| Stocks and contracts in progress3 | €128k | €118k | €118k | €134k | €135k | ▲ 0.7% |
| Stocks30/36 | - | €118k | €118k | €134k | €135k | ▲ 0.7% |
| Amounts receivable within one year40/41 | €65k | €68k | €70k | €77k | €87k | ▲ 13.5% |
| Trade receivables40 | - | €62k | €65k | €55k | €41k | ▼ 26.4% |
| Other amounts receivable41 | - | €6k | €5k | €21k | €46k | ▲ 116% |
| Cash at bank and in hand54/58 | €39k | €57k | €59k | €77k | €88k | ▲ 14.5% |
| Deferred charges and accrued income490/1 | - | €629 | €375 | €256 | €242 | ▼ 5.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €858k | €786k | €818k | €816k | €780k | ▼ 4.4% |
| Equity10/15 | €134k | €152k | €215k | €296k | €357k | ▲ 20.4% |
| Contributions10/11 | - | €12k | €12k | €12k | €12k | = |
| Reserves13 | €122k | €140k | €203k | €284k | €344k | ▲ 21.3% |
| Non-distributable reserves130/1 | - | €2k | €2k | €2k | €2k | = |
| Reserves not available under the articles1311 | - | €2k | €2k | €2k | €2k | = |
| Distributable reserves133 | - | €138k | €201k | €282k | €342k | ▲ 21.4% |
| Amounts payable17/49 | €724k | €634k | €602k | €520k | €423k | ▼ 18.6% |
| Amounts payable after more than one year17 | €532k | €431k | €369k | €280k | €220k | ▼ 21.5% |
| Financial debts170/4 | - | €431k | €369k | €280k | €220k | ▼ 21.5% |
| Amounts payable within one year42/48 | €190k | €202k | €232k | €238k | €204k | ▼ 14.4% |
| Current portion of amounts payable after more than one year42 | - | €113k | €86k | €90k | €82k | ▼ 9.6% |
| Trade debts44 | €67k | €76k | €118k | €106k | €96k | ▼ 9.8% |
| Suppliers440/4 | - | €34k | €19k | €106k | €78k | ▼ 27.1% |
| Bills of exchange payable441 | - | €42k | €99k | - | €18k | - |
| Taxes, remuneration and social security45 | - | €13k | €28k | €41k | €26k | ▼ 37.0% |
| Taxes450/3 | - | €6k | €20k | €32k | €15k | ▼ 52.2% |
| Remuneration and social security454/9 | - | €7k | €8k | €9k | €11k | ▲ 17.9% |
| Accrued charges and deferred income492/3 | - | €2k | €1k | €2k | - | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €54k | €18k | €63k | €81k | €60k | ▼ 25.3% |
| + Depreciation and write-downs630 | €90k | €90k | €87k | €63k | €61k | ▼ 2.3% |
| Operating cash flow (approximation) | €144k | €108k | €150k | €143k | €121k | ▼ 15.3% |
| Investment in fixed assets (approximation) | - | €-12k | €-115k | €-21k | €-3k | ▲ 87.3% |
| Change in cash | - | €18k | €2k | €18k | €11k | ▼ 37.4% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 61 days late
2024
27-09
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 58 days late
2023
31-12
Financial
Highest result since 2018net €81k ▲27.5%
Operating result €137k, net result €81k, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 29 days late
2022
31-12
Financial
Equity above €200kEq €215k ▲41.7%
5 profitable years in a row build equity to €215k.
30-09
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 61 days late
2021
31-12
Financial
Equity above €150kEq €152k ▲13.5%
4 profitable years in a row build equity to €152k.
17-11
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 109 days late
2020
31-12
Financial
Equity above €100kEq €134k ▲67.3%
3 profitable years in a row build equity to €134k.
21-12
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 143 days late
2019
23-12
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 145 days late
2018
28-09
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 59 days late
2017
26-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 57 days late
2016
22-11
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 114 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genappe · 1 establishment unit since 2010
Ground area
1,443 m²
Building footprint
160 m²
Volume, LiDAR
625 m³
2 parcels, Wallonia · tallest building 7.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Pharma-Thim
since 20102.192.113.787
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25113B0055/00P000 | Wallonia | 1,368 m² | 1 · 112 m² | 7.8 m · 2 fl. |
| 52065B0246/02X003 | Wallonia | 75 m² | 1 · 47 m² | - |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Pharmacie de la Bassée
BE 0700.855.286
Charleroi · Eq €356,516
Pharmacie des Bruyères Cointe
BE 0480.354.787
Liège · Eq €356,284
PHARMACIE DE MARIE - EPINOIS
BE 0450.459.684
Binche · Eq €356,103
APOTHEEK TER PLATEN
BE 0430.057.220
Gent · Eq €357,055
APOTHEEK CHARLOTTE RAES
BE 0890.110.602
Harelbeke · Eq €355,941
Of 5,221 companies in sector 47730 we hold annual accounts for 3,860. 3,462 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded21-09-2010
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
E-mail
pharmaciethimeon@gmail.com
Phone
071343392
Scores and ratios are computed by Checked and are not a credit decision.